J Sivenius Selected Research

Ischemia

3/2001	An alpha(2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats.
2/2001	Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats.
1/2001	Differential effect of the alpha2-adrenoceptor antagonist, atipamezole, in limb-placing task and skilled forepaw use following experimental stroke.
1/2001	Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat.
7/2000	Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats.
1/2000	The neuroprotective effects of (-)deprenyl in the gerbil hippocampus following transient global ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Sivenius Research Topics

Disease

17	Stroke (Strokes) 03/2013 - 04/2000
6	Ischemic Stroke 03/2013 - 02/2002
6	Ischemia 03/2001 - 01/2000
5	Infarction (Infarctions) 02/2001 - 11/2000
4	Coronary Disease (Coronary Heart Disease) 03/2013 - 09/2001
4	Myocardial Ischemia (Ischemic Heart Diseases) 03/2013 - 06/2002
3	Hypertension (High Blood Pressure) 02/2009 - 06/2002
3	Brain Ischemia (Cerebral Ischemia) 03/2001 - 07/2000
2	Overweight 07/2003 - 06/2002
2	Myocardial Infarction 02/2002 - 02/2002
2	Diabetes Mellitus 02/2002 - 02/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2001 - 04/2000
1	Cerebral Hemorrhage 10/2010
1	Hemorrhage 10/2010
1	Heart Failure 07/2009
1	Atrial Fibrillation 07/2009
1	Carotid Artery Diseases 04/2009
1	Pathologic Constriction (Stenosis) 04/2009
1	Hypercholesterolemia 07/2003
1	Heart Diseases (Heart Disease) 06/2001
1	Parkinson Disease (Parkinson's Disease) 01/2001
1	Cerebral Infarction 01/2001
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2001
1	Delirium 12/2000
1	Reperfusion Injury 11/2000
1	Obesity 04/2000

Drug/Important Bio-Agent (IBA)

4	CholesterolIBA 04/2005 - 02/2002
4	Selegiline (E250)FDA LinkGeneric 02/2001 - 01/2000
3	HDL CholesterolIBA 03/2013 - 02/2002
3	LipidsIBA 02/2002 - 04/2000
3	atipamezoleIBA 03/2001 - 07/2000
2	C-Reactive ProteinIBA 03/2013 - 02/2009
2	Antihypertensive Agents (Antihypertensives)IBA 04/2005 - 09/2001
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2002 - 06/2001
2	Pharmaceutical PreparationsIBA 02/2002 - 03/2001
2	Fibrinogen (Factor I)FDA Link 02/2002 - 02/2002
2	Saline SolutionIBA 02/2001 - 11/2000
2	Monoamine Oxidase (MAO)IBA 01/2001 - 11/2000
1	LDL CholesterolIBA 03/2013
1	HDL LipoproteinsIBA 03/2013
1	APTIBA 10/2010
1	Natriuretic PeptidesIBA 07/2009
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2009
1	Atrial Natriuretic Factor (ANF)IBA 07/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2009
1	Coloring Agents (Dyes)IBA 08/2007
1	Rose BengalIBA 08/2007
1	Oxygen (Dioxygen)IBA 04/2005
1	Indicators and Reagents (Reagents)IBA 07/2003
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2002
1	beta Carotene (Betacarotene)FDA Link 06/2001
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2001
1	LycopeneIBA 06/2001
1	Dexmedetomidine FDA Link 01/2001
1	CatecholaminesIBA 01/2001
1	lazabemideIBA 11/2000
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2000
1	Desipramine (Pertofrane)FDA LinkGeneric 07/2000
1	Insulin (Novolin)FDA Link 04/2000
1	Neuroprotective AgentsIBA 01/2000

Therapy/Procedure

2	Therapeutics 10/2010 - 03/2001
1	Vascular Surgical Procedures 04/2009
1	Carotid Endarterectomy 04/2009
1	Electrocoagulation (Electrocautery) 01/2001
1	Drug Therapy (Chemotherapy) 01/2001
1	Long-Term Care 12/2000